These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1461300)

  • 41. Smear biopsies: a cause of negative follow-up biopsies in patients with premalignant conditions of the uterine cervix.
    Berner A; Høeg K; Oppedal BR
    Diagn Gynecol Obstet; 1980; 2(2):99-101. PubMed ID: 7439010
    [TBL] [Abstract][Full Text] [Related]  

  • 42. False-negative cytology rates in patients in whom invasive cervical cancer subsequently developed.
    Morell ND; Taylor JR; Snyder RN; Ziel HK; Saltz A; Willie S
    Obstet Gynecol; 1982 Jul; 60(1):41-5. PubMed ID: 7088449
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Milwaukee deaths reignite critical issues in cervical cancer screening.
    Voelker R
    JAMA; 1995 May 24-31; 273(20):1559-60. PubMed ID: 7745755
    [No Abstract]   [Full Text] [Related]  

  • 44. Papanicolaou smear sensitivity for the detection of adenocarcinoma of the cervix: a study of 49 cases.
    Krane JF; Granter SR; Trask CE; Hogan CL; Lee KR
    Cancer; 2001 Feb; 93(1):8-15. PubMed ID: 11241260
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Consequences of incorrect interpretation of vaginal smear tests in a screening program].
    Lynge E; Arffmann E; Poll P; Andersen PK
    Ugeskr Laeger; 1994 Apr; 156(17):2594-6. PubMed ID: 8016968
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Liquid based cytology in cervical cancer screening.
    Denton KJ
    BMJ; 2007 Jul; 335(7609):1-2. PubMed ID: 17615183
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Problems of false negative cytological findings in the early diagnosis of cervix neoplasms].
    Tilch G; Miesel U
    Z Arztl Fortbild (Jena); 1979 Aug; 73(16):766-9. PubMed ID: 494673
    [No Abstract]   [Full Text] [Related]  

  • 48. Letter: Who is responsible for the false-negative smear?
    Rubio CA; Lagerlöf B
    Acta Cytol; 1975; 19(4):319. PubMed ID: 1057831
    [No Abstract]   [Full Text] [Related]  

  • 49. Cytopathology of false negatives preceding cervical carcinoma.
    DeMay RM
    Am J Obstet Gynecol; 1996 Oct; 175(4 Pt 2):1110-3. PubMed ID: 8885795
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Commentary: Liquid automation refreshes Dr Papanicolaou.
    Watts G
    BMJ; 2007 Jul; 335(7609):35-6. PubMed ID: 17615223
    [No Abstract]   [Full Text] [Related]  

  • 51. [Cytological control in complex treatment of cervical cancer].
    Birbraer VM; Pankov AK; Kolesnikova VA; Rozenko LIa
    Vestn Akad Med Nauk SSSR; 1976; (6):54-7. PubMed ID: 997852
    [No Abstract]   [Full Text] [Related]  

  • 52. High resolution analysis of cervical cells--a progress report.
    Poulsen RS; Oliver LH; Cahn RL; Louis C; Toussaint G
    J Histochem Cytochem; 1977 Jul; 25(7):689-95. PubMed ID: 330722
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Contamination during the staining process of cytological cervixuterine smears].
    Uribe L; Biershwale M
    Rev Chil Obstet Ginecol; 1977; 42(2):105-9. PubMed ID: 77538
    [No Abstract]   [Full Text] [Related]  

  • 54. Automated cytologic screening devices and malpractice liability.
    Skoumal SM; Cohen MB
    Diagn Cytopathol; 1997 Aug; 17(2):85-7. PubMed ID: 9258613
    [No Abstract]   [Full Text] [Related]  

  • 55. Mistakes in cytopathology.
    Shane JJ
    Diagn Cytopathol; 1997 Dec; 17(6):488-90. PubMed ID: 9407216
    [No Abstract]   [Full Text] [Related]  

  • 56. NeoPath, Inc. NeoPath AutoPap 300 Automatic Pap Screener System.
    Patten SF; Lee JS; Nelson AC
    Acta Cytol; 1996; 40(1):45-52. PubMed ID: 8604574
    [No Abstract]   [Full Text] [Related]  

  • 57. A perspective on modern quality control methods.
    Hutchinson ML; Lapidus SN; Inhorn SL; Papillo J
    Acta Cytol; 1996; 40(4):837-41. PubMed ID: 8693909
    [No Abstract]   [Full Text] [Related]  

  • 58. False negative cervical smears.
    Macgregor JE
    Br J Obstet Gynaecol; 1993 Sep; 100(9):801-2. PubMed ID: 8217996
    [No Abstract]   [Full Text] [Related]  

  • 59. Reducing variation: diagnostics: from 20 weeks to just 14 days.
    Health Serv J; 2011 Sep; Suppl():19. PubMed ID: 22053509
    [No Abstract]   [Full Text] [Related]  

  • 60. Negative cytology preceding cervical cancer: causes and prevention.
    Rubio CA
    J Clin Pathol; 1994 Feb; 47(2):188. PubMed ID: 8132842
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.